Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitephenex-pharma.com
CategoryBioTech
Phone49-621-671960-0
Emailinfo@phenex-pharm...
Employees
Founded2002

Offices

Head Office
Donnersbergweg 1
Ludwigshafen, 67059, DEU
Research Site
Waldhofer Str. 104
Heidelberg, 69123, DEU

People

CEO
Chairman of the Supervisory Board
CFO
VP Discovery Services
Member of the Supervisory Board
Vice Chairman of the Supervisory Board
Member of the Supervisory Board
Member of the Supervisory Board
Member of the Supervisory Board

Funding

Tags

Phenex Pharmaceuticals

Phenex is a privately financed biotechnology company that focuses on developing novel drug candidates that act on Nuclear Receptors, a pharmacologically well accepted drug target class. Nuclear receptors are of major importance for the body’s homeostasis, as they integrate different intra- and extracellular signalling to initiate and regulate gene expression programs. This key role in a wide variety of signalling pathways qualifies them as important pharmacological targets. Nuclear receptor modulating drugs account for about 10% revenues of the total ethical drug market, applied in different indications, such as Hormone Replacement Therapy, Women’s Health, Inflammation, Diabetes, Cancer and Dermatology.

Recent Milestones

Videos

Screenshots

Phenex Pharmaceuticals screenshot
Above: Phenex Pharmaceuticals
Uploaded: 8/30/10

Sources

  1. Phenex AG closes its first financing round with a total volume of 4,2 M Euro (phenex-pharma.com) [edit]
  2. Phenex Raises €6M in Series C Financing (finsmes.com) [edit]
  3. phenex-pharma.com [edit]
    phenex-pharma.com [edit]
Edit This Page
Last Edited 11/6/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy